Pharma Pulse 3/5/25: Tariffs Official on Canada and Mexico, The Future of Medication Safety and Efficiency & more
The latest news for pharma industry insiders.
Tariffs on Canada and Mexico Now Official
The 25% tax on various imports have gone into effect, resulting in retaliatory tariffs from the impacted nations.
Pharmacy Automation: The Future of Medication Safety and Efficiency
Notable advancements include machine learning and predictive analytics, among others.
TSMC, the Chip Giant, Is to Spend $100 Billion in U.S. Over the Next 4 Years
The investment plan, announced at the White House, was made as the Trump administration pushes to bring chip making back to the United States.
Medable Inc. has announced that its eConsent and eCOA solutions have been approved for use in two clinical studies in eight countries outside of the European Union by France’s Commission Nationale de l’Informatique et des Libertés (CNIL). This makes Medable uniquely capable of operating as a data processor outside of the CNIL MR-001 Reference Methodology requirements for a France-based clinical trial sponsor.
Aspargo Laboratories, Inc. on LinkedIn
We are incredibly excited to share insights from our CEO, Michael Demurjian, on the future of medication delivery. In a recent article in Pharmaceutical Executive, he discusses the transformation of pill medications into oral liquid forms, a game-changer for both patients and healthcare professionals. This innovative approach often provides faster absorption, improved bioavailability, and better patient adherence—leading to more effective treatments and better outcomes.
At Aspargo, we are committed to pioneering solutions like these, pushing the boundaries of traditional drug delivery to meet the evolving needs of the healthcare industry. The future of medicine is here, and it’s liquid.
Read more here: https://lnkd.in/eXCKXDzT
#PharmaInnovation #PharmaExec #PatientCentric #AspargoLabs #LiquidSuspension
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs
